SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (12801)12/22/1997 11:05:00 PM
From: Harrison Hickman  Read Replies (1) | Respond to of 32384
 
tonyt:

>> I think the biotech weakness is due to Asia concerns<<(Andrew H)

>>I can understand why techs (i.e. DELL, CPQ), who have a decent percentage of revenues from Asia falling on these concerns, but most biotechs do not have this problem.<<

The Asian problem I most closely associate with LGND is Chinese water torture. In my dreams, I also associate LGND with C. Chan and his #1 son, but I have never been able to determine why. Any ideas (other than rereading Jung)?

Harrison Hickman



To: tonyt who wrote (12801)12/23/1997 1:13:00 AM
From: Andrew H  Read Replies (3) | Respond to of 32384
 
What I was trying to say was that at times when the market is especially nervous over the possibilities of a general earnings decline and a worldwide economic slowdown (like with the Asian crisis) investors are even less likely than usual to put money into stocks that are not making money, even if they have a bright future.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News